Combination therapy with gemcitabine and ZD6126

Details for Australian Patent Application No. 2003274306 (hide)

International Classifications

Event Publications

12 February 2004 Complete Application Filed

Priority application(s): 0223379.9 09.10.02 GB

3 June 2004 Application Open to Public Inspection

Published as AU-B-2003274306

9 June 2005 Amendment Made

The nature of the amendment is: Amend the name of the applicant from AstraZeneca AB to Angiogene Pharmaceuticals Limited

8 February 2007 Application Accepted

Published as AU-B-2003274306

7 June 2007 Standard Patent Sealed

30 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.